SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Details Narrative) - USD ($)					3 Months Ended
	Jul. 26, 2022	Jul. 22, 2022	May 03, 2022	Feb. 15, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Common stock voting rights					The holders of the Company’s common stock are entitled to one vote per share.
Common stock, shares authorized					100,000,000		100,000,000
Preferred stock, shares authorized					20,000,000		20,000,000
Incentive plan description			(i) increase the aggregate number of shares available for the grant of awards by 146,083 shares to a total of 200,000 shares, and (ii) add an “evergreen” provision whereby the number of shares authorized for issuance pursuant to awards under the Incentive Plan will be automatically increased on the first trading date immediately following the date the Company issues any share of Common Stock (defined below) to any person or entity, to the extent necessary so that the number of shares of the Company’s Common Stock authorized for issuance under the Incentive Plan will equal the greater of (x) 200,000 shares, and (y) 15% of the total number of shares of the Company’s Common Stock outstanding as of such issuance date. The Plan Amendment was approved by the Company’s stockholders at a special meeting of the Company’s stockholders held on July 14, 2022.
Stock based compensation, expenses					$ 484,749	$ 719,767
Share-Based Payment Arrangement, Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock based compensation, expenses					48,086	36,989
Stock-based compensation, unamortized					$ 192,764
Weighted average period					1 year 8 months 12 days
Restricted Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Stock based compensation, expenses					$ 0	11,863
Common stock vested restricted stock units					708
Restricted Stock Units (RSUs) [Member]
Subsidiary, Sale of Stock [Line Items]
Stock based compensation, expenses					$ 484,749	$ 719,767
Stock-based compensation, unamortized					$ 2,790,640
Weighted average period					2 years 7 months 6 days
Common stock vested restricted stock units					2,820
Restricted Stock Units (RSUs) [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock vested restricted stock units					65,312
Common stock vested restricted stock units					1,313
RD Offering and Pipe Investment Options [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from RD offerings	$ 8,000,000
Offerings costs	7,100,000
Payments of allocated equity	3,200,000
Payments of investment option liability	4,300,000
Payments of stock issuance costs recorded expense	$ 400,000
Registered Direct Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues		375,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		258,500
Proceeds from issuance of warrants		$ 3,000,000
Sale of Stock, Number of Shares Issued in Transaction		116,500
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.0001
PIPE Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues		625,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		509,000
Proceeds from issuance of warrants		$ 5,000,000
Sale of Stock, Number of Shares Issued in Transaction		116,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.0001
Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				60,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				60,000
Stock issued during period shares warrant exercised.				60,000
Proceeds from Issuance Initial Public Offering				$ 9,100,000
Deferred Offering Costs				5,800,000
[custom:WarrantLiability-0]				3,600,000
Proceeds from issuance of warrants				$ 300,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				400,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				400,000
Proceeds from common stock				$ 10,000,000